Schedule of Summarizes Information About Stock Options (Details) (Parenthetical) - shares		3 Months Ended	12 Months Ended
		Mar. 31, 2023	Dec. 31, 2022
2018 Equity Plan [Member]
Stock options, Granted	[1]	2,697,500
2018 Equity Plan [Member] | Lucid Diagnostics Inc [Member]
Number of stock options granted. shares		50,000
Stock options, Granted		423,300	423,300
Parent Company [Member] | 2014 Equity Plan [Member]
Number of stock options granted. shares		500,854	500,854

[1] Stock options granted under the Lucid Diagnostics 2018 Equity Plan and those granted outside such plan generally vest one-third in one year then ratably over the next eight quarters, and have a ten-year contractual term from date-of-grant.